Trial
NCT04345289
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Thomas Benfield
Collaborators
—
Condition
COVID
Intervention
Convalescent anti-SARS-CoV-2 plasma
Why stopped
DSMB advise due to high probability of futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-04